Congress Begins Shaping A Research Bonanza

Question of the day: Why is basic research, particularly biomedical research, like highways and bridges? Answer: Because Congress loves them both, especially in this election year. 'MIRACULOUS': NIH, under the direction of Harold Varmus, would get an 8.4 percent increase in its budget under President Clinton's proposed plan. For that reason, as much as any other, the spending plan that Congress is now writing for the fiscal year that begins October 1 shapes up as one of the best research-fundin

| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Question of the day: Why is basic research, particularly biomedical research, like highways and bridges? Answer: Because Congress loves them both, especially in this election year.

Varmus
'MIRACULOUS': NIH, under the direction of Harold Varmus, would get an 8.4 percent increase in its budget under President Clinton's proposed plan.
For that reason, as much as any other, the spending plan that Congress is now writing for the fiscal year that begins October 1 shapes up as one of the best research-funding budgets in decades, and possibly the best ever.

President Bill Clinton set the tone last month, when he sent Congress a fiscal year (FY) 1999 budget that proposed a $2 billion increase, or 3 percent, in overall federal R&D spending. Clinton plans 8 percent jumps for both defense and civilian basic research, a 6 percent increase for civilian R&D, and a 0.3 percent trim in defense R&D that would raise ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Bruce Agnew

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Discover a serum-free way to produce dendritic cells and macrophages for cell therapy applications.

Optimizing In Vitro Production of Monocyte-Derived Dendritic Cells and Macrophages

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with Lipid Nanoparticles

Thermo Fisher Logo